These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15929553)

  • 21. Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism.
    Kozina EA; Khakimova GR; Khaindrava VG; Kucheryanu VG; Vorobyeva NE; Krasnov AN; Georgieva SG; Kerkerian-Le Goff L; Ugrumov MV
    J Neurol Sci; 2014 May; 340(1-2):198-207. PubMed ID: 24768159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: a comparison with other types of grafts as controls.
    Taylor JR; Elsworth JD; Roth RH; Sladek JR; Collier TJ; Redmond DE
    Exp Brain Res; 1991; 85(2):335-48. PubMed ID: 1893983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure fails to produce delayed degeneration of substantia nigra neurons in monkeys.
    Garrido-Gil P; Belzunegui S; San Sebastián W; Izal-Azcárate A; López B; Marcilla I; Luquin MR
    J Neurosci Res; 2009 Feb; 87(2):586-97. PubMed ID: 18798285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Admixing of MPTP-Resistant and Susceptible Mice Strains Augments Nigrostriatal Neuronal Correlates to Resist MPTP-Induced Neurodegeneration.
    Vidyadhara DJ; Yarreiphang H; Raju TR; Alladi PA
    Mol Neurobiol; 2017 Oct; 54(8):6148-6162. PubMed ID: 27704331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective action of recombinant neurturin on dopaminergic neurons in substantia nigra in a rhesus monkey model of Parkinson's disease.
    Li H; He Z; Su T; Ma Y; Lu S; Dai C; Sun M
    Neurol Res; 2003 Apr; 25(3):263-7. PubMed ID: 12739234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
    Jakowec MW; Nixon K; Hogg E; McNeill T; Petzinger GM
    J Neurosci Res; 2004 May; 76(4):539-50. PubMed ID: 15114626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parkinsonian monkeys with prior levodopa-induced dyskinesias followed by fetal dopamine precursor grafts do not display graft-induced dyskinesias.
    Kordower JH; Vinuela A; Chu Y; Isacson O; Redmond DE
    J Comp Neurol; 2017 Feb; 525(3):498-512. PubMed ID: 27418401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway.
    Riverol M; Ordóñez C; Collantes M; DiCaudo C; Peñuelas I; Arbizu J; Marcilla I; Luquin MR
    Neurobiol Dis; 2014 Feb; 62():250-9. PubMed ID: 24076099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopaminergic innervation of the subthalamic nucleus in the normal state, in MPTP-treated monkeys, and in Parkinson's disease patients.
    François C; Savy C; Jan C; Tande D; Hirsch EC; Yelnik J
    J Comp Neurol; 2000 Sep; 425(1):121-9. PubMed ID: 10940946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modification of the number and phenotype of striatal dopaminergic cells by carotid body graft.
    San Sebastián W; Guillén J; Manrique M; Belzunegui S; Ciordia E; Izal-Azcárate A; Garrido-Gil P; Vázquez-Claverie M; Luquin MR
    Brain; 2007 May; 130(Pt 5):1306-16. PubMed ID: 17439984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice deficient in CuZn-superoxide dismutase or glutathione peroxidase.
    Zhang J; Graham DG; Montine TJ; Ho YS
    J Neuropathol Exp Neurol; 2000 Jan; 59(1):53-61. PubMed ID: 10744035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
    Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efferent synaptic connections of dopaminergic neurons grafted into the caudate nucleus of experimentally induced parkinsonian monkeys are different from those of control animals.
    Leranth C; Sladek JR; Roth RH; Redmond DE
    Exp Brain Res; 1998 Dec; 123(3):323-33. PubMed ID: 9860271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cooperative synthesis of dopamine by non-dopaminergic neurons as a compensatory mechanism in the striatum of mice with MPTP-induced Parkinsonism.
    Kozina EA; Kim AR; Kurina AY; Ugrumov MV
    Neurobiol Dis; 2017 Feb; 98():108-121. PubMed ID: 27940203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fetal dopamine cell survival after transplantation is dramatically improved at a critical donor gestational age in nonhuman primates.
    Sladek JR; Elsworth JD; Roth RH; Evans LE; Collier TJ; Cooper SJ; Taylor JR; Redmond DE
    Exp Neurol; 1993 Jul; 122(1):16-27. PubMed ID: 8101820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synaptic microcircuitry of tyrosine hydroxylase-containing neurons and terminals in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys.
    Mazloom M; Smith Y
    J Comp Neurol; 2006 Apr; 495(4):453-69. PubMed ID: 16485290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FGF-2 deficiency does not alter vulnerability of the dopaminergic nigrostriatal system towards MPTP intoxication in mice.
    Zechel S; Jarosik J; Kiprianova I; Schober A; Unsicker K; von Bohlen und Halbach O
    Eur J Neurosci; 2006 Mar; 23(6):1671-5. PubMed ID: 16553632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells.
    Redmond DE; Bjugstad KB; Teng YD; Ourednik V; Ourednik J; Wakeman DR; Parsons XH; Gonzalez R; Blanchard BC; Kim SU; Gu Z; Lipton SA; Markakis EA; Roth RH; Elsworth JD; Sladek JR; Sidman RL; Snyder EY
    Proc Natl Acad Sci U S A; 2007 Jul; 104(29):12175-80. PubMed ID: 17586681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of striatal transplantation of cells transfected with GDNF gene without pre- and pro-regions in mouse model of Parkinson's disease.
    Revishchin A; Moiseenko L; Kust N; Bazhenova N; Teslia P; Panteleev D; Kovalzon V; Pavlova G
    BMC Neurosci; 2016 Jun; 17(1):34. PubMed ID: 27286696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recovery of behavioral symptoms in hemi-parkinsonian rhesus monkeys through combined gene and stem cell therapy.
    Zhou Y; Sun M; Li H; Yan M; He Z; Wang W; Wang W; Lu S
    Cytotherapy; 2013 Apr; 15(4):467-80. PubMed ID: 23403361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.